http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106459088-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e11cab7fc001615fa5064301b2db3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a5f2dc8847b3d6fe32e55f0869f290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e096d84a366ba039a9fd91d9acb64f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da85489d4ab5f2aa2b2442197fd5c59f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7221ba3561b2c9ab2071eeadaccb975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058a16f08c7bf9e1b35ae5a93e5990fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95ecec04f576a8e65cf874b8c7e82f79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b14063a157ea005b9f45a08e4cc8ba2d
publicationDate 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106459088-A
titleOfInvention 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazole- 4-yl amides
abstract The present invention relates to compounds, tautomers and pharmaceutically acceptable salts of the disclosed compounds, wherein said compounds have the structure of formula I , and the variable R1 is as defined in the specification. The corresponding pharmaceutical composition, treatment method, synthesis method and intermediate are also disclosed.
priorityDate 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014045162-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102171221-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468299940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468306849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468298301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468298300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468301317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468247335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468267003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468301735

Total number of triples: 40.